Pathogen-inactivated red blood cell compositions
US10357516B2 · kind B2 · utility
10Cited by
40References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 20, 2017 |
| Grant date | Jul 23, 2019 |
| Priority date | — |
| Expiry date | Jul 30, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61L2/0082
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides pathogen-inactivated red blood cell compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.